Berjano, Pedro
Xu, Ming
Damilano, Marco
Scholl, Thomas
Lamartina, Claudio
Jekir, Michael
Galbusera, Fabio
Article History
Received: 9 September 2018
Revised: 15 March 2019
Accepted: 13 May 2019
First Online: 25 May 2019
Compliance with ethical standards
:
: Dr. Pedro Berjano has received grants from NuVasive, DePuy Synthes, K2M, Speaker honorarium from Medacta and NuVasive. Dr. Ming Xu is former employee of NuVasive and owns stock of NuVasive. Mr. Thomas Scholl and Mr. Michael Jekir are current employees of NuVasive and own stock of NuVasive. Dr. Marco Damilano has received grants from NuVasive and K2M No honorarium for speaker. Dr. Claudio Lamartina is consultant for Depuy-Sythes, K2M, Medacta, NuVasive, Sintea, Zimmer, Deputy Editor for clinical science of European Spine Journal, and past chairman of AOSpine Board of Europe and Africa.